Merck & Co. Files 8-K on Financial Instruments

TL;DR

Merck filed an 8-K on 9/9/25 detailing its common stock and various notes due between 2026 and 2054.

AI Summary

On September 9, 2025, Merck & Co., Inc. filed an 8-K report detailing various financial instruments, including common stock and several series of notes with varying interest rates and maturity dates. The filing does not disclose any specific transactions or events beyond the reporting of these financial details.

Why It Matters

This filing provides investors with an update on Merck's outstanding debt and equity, offering transparency into the company's capital structure.

Risk Assessment

Risk Level: low — The filing is a routine disclosure of financial instruments and does not indicate any new risks or material changes.

Key Numbers

• 2026 — Note Maturity Year (Earliest maturity date for notes listed)
• 2054 — Note Maturity Year (Latest maturity date for notes listed)

Key Players & Entities

• Merck & Co., Inc. (company) — Filer of the 8-K report
• September 9, 2025 (date) — Date of the report
• 0000310158-25-000047 (other) — Accession number for the filing
• 2834 (other) — Standard Industrial Classification code for Pharmaceutical Preparations

FAQ

From the Filing

0000310158-25-000047.txt : 20250909 0000310158-25-000047.hdr.sgml : 20250909 20250909163309 ACCESSION NUMBER: 0000310158-25-000047 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 22 CONFORMED PERIOD OF REPORT: 20250909 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20250909 DATE AS OF CHANGE: 20250909 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Merck & Co., Inc. CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 251303680 BUSINESS ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 BUSINESS PHONE: 908-740-4000 MAIL ADDRESS: STREET 1: 126 EAST LINCOLN AVENUE STREET 2: P.O. BOX 2000 CITY: RAHWAY STATE: NJ ZIP: 07065 FORMER COMPANY: FORMER CONFORMED NAME: Merck & Co. Inc. DATE OF NAME CHANGE: 20091103 FORMER COMPANY: FORMER CONFORMED NAME: SCHERING PLOUGH CORP DATE OF NAME CHANGE: 19920703 8-K 1 mrk-20250909.htm 8-K mrk-20250909 0000310158 False 0000310158 2025-09-09 2025-09-09 0000310158 us-gaap:CommonStockMember 2025-09-09 2025-09-09 0000310158 mrk:A1.875NotesDue2026Member 2025-09-09 2025-09-09 0000310158 mrk:A3.250NotesDue2032Member 2025-09-09 2025-09-09 0000310158 mrk:A2.500NotesDue2034Member 2025-09-09 2025-09-09 0000310158 mrk:A1.375NotesDue2036Member 2025-09-09 2025-09-09 0000310158 mrk:A3.500NotesDue2037Member 2025-09-09 2025-09-09 0000310158 mrk:A3.700NotesDue2044Member 2025-09-09 2025-09-09 0000310158 mrk:A3.750NotesDue2054Member 2025-09-09 2025-09-09 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C.  20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) September 9, 2025 Merck & Co., Inc. (Exact name of registrant as specified in its charter) New Jersey 1-6571 22-1918501 (State or other jurisdiction (Commission (I.R.S Employer of incorporation) File Number) Identification No.) 126 East Lincoln Avenue , Rahway , New Jersey 07065 (Address of principal executive offices) (Zip Code) (Registrant’s telephone number, including area code) ( 908 ) 740-4000 Not Applicable (Former name or former address, if changed since last report.) Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock ($0.50 par value) MRK New York Stock Exchange 1.875% Notes due 2026 MRK/26 New York Stock Exchange 3.250% Notes due 2032 MRK/32 New York Stock Exchange 2.500% Notes due 2034 MRK/34 New York Stock Exchange 1.375% Notes due 2036 MRK 36A New York Stock Exchange 3.500% Notes due 2037 MRK/37 New York Stock Exchange 3.700% Notes due 2044 MRK/44 New York Stock Exchange 3.750% Notes due 2054 MRK/54 New York Stock Exchange Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended